GLUE

Monte Rosa Therapeutics (GLUE)

About Monte Rosa Therapeutics (GLUE)

Monte Rosa Therapeutics, Inc. operates as a biotechnology company, which engages in the developing of precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Details

Daily high
$17.63
Daily low
$16.57
Price at open
$16.84
52 Week High
$17.63
52 Week Low
$3.50
Market cap
1.1B
Dividend yield
0.00%
Volume
659,174
Avg. volume
983,654
P/E ratio
55.21

Monte Rosa Therapeutics News

Details

Daily high
$17.63
Daily low
$16.57
Price at open
$16.84
52 Week High
$17.63
52 Week Low
$3.50
Market cap
1.1B
Dividend yield
0.00%
Volume
659,174
Avg. volume
983,654
P/E ratio
55.21